This center treats primary substance use disorders and co-occurring mental health conditions. Your treatment plan addresses each condition at once with personalized, compassionate care for comprehensive healing.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
This provider hasn't verified their profile's information. Are you the owner of this center? Claim your listing to better manage your presence on Recovery.com.
This center treats primary substance use disorders and co-occurring mental health conditions. Your treatment plan addresses each condition at once with personalized, compassionate care for comprehensive healing.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
Ascension Center for Recovery accepts Aetna, Anthem, Humana, WellCare, Passport by Molina Healthcare, and Medicaid. Call us to verify coverage.
Ascension Center for Recovery in Bardstown, Kentucky, welcomes adults seeking freedom from substance use, offering a safe, supportive space to heal. With a person-centered approach, the center addresses emotional, psychological, and physical well-being. Their mission is to restore self-worth and break barriers caused by addiction, empowering individuals to live meaningful, fulfilling lives.
Clients receive personalized care through short- and long-term residential programs, with the long-term program offering a 4- to 6-week duration. Each includes medical support, therapy, and relapse prevention. Services like crisis intervention, psychiatric care, and 12-step curriculum ensure a strong foundation for recovery. Each plan is designed to guide patients from recovery to aftercare, focusing on both immediate needs and long-term success.
In a warm, residential setting, clients share rooms, meals, and daily routines that promote reflection and discipline. Mornings begin with health walks and devotionals, followed by structured activities and therapeutic groups. With spaces for learning and connection including a classroom and dining area, the facility offers a steady rhythm that nurtures both healing and personal growth.
This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT
Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.
Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.
Suboxone®, Subutex®, Sublocade®, Zubsolv®
Buprenorphine is a partial opioid agonist used to treat opioid use disorder. It activates opioid receptors to reduce cravings and withdrawal but has a ceiling effect, meaning it produces less euphoria and respiratory depression than full opioids.
Buprenorphine binds tightly to opioid receptors, blocking other opioids from attaching and reducing the risk of misuse. It's often combined with naloxone (as in Suboxone®) to discourage injection misuse and is available in daily or monthly forms.